October 30, 2018 08:57 AM EDT

Problems, problems, problems: But Alkermes will fight it out this week over the FDA’s objections to its big depression drug ALKS 5461

Alkermes tried several new things when their researchers tested ALKS 5461 for major depression in clinical trials. Now they have to see if they can …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Prob­lems, prob­lems, prob­lems: But Alk­er­mes will fight it out this week over the FDA’s ob­jec­tions to its big de­pres­sion drug ALKS 5461